Momenta Pharmaceuticals to Present At Upcoming Conferences

CAMBRIDGE, Mass., Nov. 5, 2008 (GLOBE NEWSWIRE) — Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that management will present a company overview at two upcoming conferences.

    * Craig Wheeler, Chief Executive Officer, will present at the 2008    Deutsche Bank Biotech Boston Confab in Boston at the Taj Boston    Hotel on Tuesday, November 11th at 10:50 a.m. EST.   * Rick Shea, Chief Financial Officer, will present at the Rodman    and Renshaw 10th Annual Healthcare Conference in New York on    Tuesday, November 11th at 12:25 p.m. EST at The New York Palace    Hotel. 

A live audio webcast of each presentation will be available on the “Investors” section of the Company’s website located at www.momentapharma.com. A replay of the presentation will be posted on the Momenta website approximately one hour after the event and will be available through February 11, 2009.

About Momenta

Momenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex mixture drugs. Momenta is applying its technology to the development of generic versions of complex drug products, as well as to the discovery and development of novel drugs. Momenta was founded in 2001 based on technology initially developed at Massachusetts Institute of Technology and is headquartered in Cambridge, MA.

To receive additional information about Momenta, please visit the website at www.momentapharma.com, which does not form a part of this press release.

Our logo, trademarks, and service marks are the property of Momenta Pharmaceuticals, Inc. All other trade names, trademarks, or service marks are property of their respective owners.

This news release was distributed by GlobeNewswire, www.globenewswire.com

 CONTACT:  Momenta Pharmaceuticals, Inc.           Investor Relations           Beverly Holley           617-395-5189